Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs202199891
rs202199891
APC
0.010 GeneticVariation BEFREE A genetic variant in the APC gene co-segregating with PHPT (p.Val530Ala) was detected in a family whose affected relatives had additional tumors, including colonic polyposis. 31486992

2020

dbSNP: rs1544410
rs1544410
VDR
0.010 GeneticVariation BEFREE We conducted meta-analyses for calcium-sensing receptor gene (CaSR) rs1801725 polymorphism in patients with primary hyperparathyroidism and vitamin D receptor gene (VDR) rs1544410 polymorphism in patients with end-stage renal disease (ESRD). 29794776

2018

dbSNP: rs1081725
rs1081725
0.010 GeneticVariation BEFREE Our results indicate that SNPs of CASR gene A986S (rs1081725) and R990G (rs1042636) may increase the risk of PHPT, and the polymorphisms can potentially be used as important biological markers for early diagnosis of PHPT. 26710757

2016

dbSNP: rs146646971
rs146646971
RET
0.010 GeneticVariation BEFREE None of the K666N DNA variant carriers had evidence of primary hyperparathyroidism or pheochromocytoma. 27673361

2016

dbSNP: rs1501899
rs1501899
0.010 GeneticVariation BEFREE Two single-nucleotide polymorphisms (SNPs) at the calcium-sensing receptor (CASR) gene were previously associated with kidney stones in patients with primary hyperparathyroidism (PHPT): rs1501899, likely associated with a decrease in CASR expression, and Arg990Gly, causing a gain of CASR function. 24832896

2015

dbSNP: rs61734277
rs61734277
0.010 GeneticVariation BEFREE The aims of the study were to 1) assess the frequency of Y282D in Italian primary hyperparathyroidism (PHPT) and control (C) populations, 2) test for association of 282D with PHPT and its phenotypic features, and 3) compare the transactivation potency of GCM2 282D relative to wild-type Y282. 25279501

2014

dbSNP: rs121909293
rs121909293
0.010 GeneticVariation BEFREE However, it only indicates that the CTRC (p.R254W) mutation might also contribute to the panel of mutations ( SPINK1 and CFTR) that have been formerly reported to elevate pancreatitis susceptibility in pHPT. 20625975

2011

dbSNP: rs2073618
rs2073618
0.010 GeneticVariation BEFREE We found no differences between genotypes of the OPG rs2073618 (1181 G/C) SNP with regard to BMD in the PHPT subjects. 22185226

2011

dbSNP: rs3102735
rs3102735
0.010 GeneticVariation BEFREE Subjects with PHPT and minor homocygote genotype (GG) for the OPG rs3102735 (163 A/G) and OPG rs3134070 (245 T/G) SNPs have lower BMD in the distal radius, and this association does not appear to be mediated by differences in PTH serum levels. 22185226

2011

dbSNP: rs3134070
rs3134070
0.010 GeneticVariation BEFREE Subjects with PHPT and minor homocygote genotype (GG) for the OPG rs3102735 (163 A/G) and OPG rs3134070 (245 T/G) SNPs have lower BMD in the distal radius, and this association does not appear to be mediated by differences in PTH serum levels. 22185226

2011

dbSNP: rs61734659
rs61734659
0.010 GeneticVariation BEFREE PRSS2 (p.G191R) mutation was present in 1 patient with pancreatitis (3.2%) and in 6 pHPT controls (6%) (P=1). 20625975

2011

dbSNP: rs748405415
rs748405415
0.010 GeneticVariation BEFREE PRSS2 (p.G191R) mutation was present in 1 patient with pancreatitis (3.2%) and in 6 pHPT controls (6%) (P=1). 20625975

2011

dbSNP: rs7652589
rs7652589
0.010 GeneticVariation BEFREE The A minor alleles at these two SNPs were more frequent in stone forming (n=157) than in stone-free (n=175) PHPT patients (rs7652589: 36.9 vs 27.1%, P=0.007; rs1501899: 37.1 vs 26.4%, P=0.003). 21183554

2011

dbSNP: rs111033565
rs111033565
0.010 GeneticVariation BEFREE These individuals and 50 patients with pHPT without pancreatitis were analyzed for mutations in the serine protease inhibitor Kazal type I (SPINK1) gene (N34S) and the cationic trypsinogen gene (PRSS1) (N29I, R122H) by melting curve analysis and DNA sequencing. 18076731

2008

dbSNP: rs111033566
rs111033566
0.010 GeneticVariation BEFREE These individuals and 50 patients with pHPT without pancreatitis were analyzed for mutations in the serine protease inhibitor Kazal type I (SPINK1) gene (N34S) and the cationic trypsinogen gene (PRSS1) (N29I, R122H) by melting curve analysis and DNA sequencing. 18076731

2008

dbSNP: rs1223231582
rs1223231582
0.010 GeneticVariation BEFREE Four of 25 patients with pHPT and pancreatitis carried the N34S missense mutation in the SPINK1 gene (16%), while all 50 controls (pHPT without pancreatitis) showed no mutation in SPINK1 or PRSS1 genes (P < 0.05 vs controls, P < 0.001 vs general population). 18076731

2008

dbSNP: rs1451011538
rs1451011538
0.010 GeneticVariation BEFREE These individuals and 50 patients with pHPT without pancreatitis were analyzed for mutations in the serine protease inhibitor Kazal type I (SPINK1) gene (N34S) and the cationic trypsinogen gene (PRSS1) (N29I, R122H) by melting curve analysis and DNA sequencing. 18076731

2008

dbSNP: rs267606982
rs267606982
0.010 GeneticVariation BEFREE These individuals and 50 patients with pHPT without pancreatitis were analyzed for mutations in the serine protease inhibitor Kazal type I (SPINK1) gene (N34S) and the cationic trypsinogen gene (PRSS1) (N29I, R122H) by melting curve analysis and DNA sequencing. 18076731

2008

dbSNP: rs397508687
rs397508687
0.010 GeneticVariation BEFREE These individuals and 50 patients with pHPT without pancreatitis were analyzed for mutations in the serine protease inhibitor Kazal type I (SPINK1) gene (N34S) and the cationic trypsinogen gene (PRSS1) (N29I, R122H) by melting curve analysis and DNA sequencing. 18076731

2008

dbSNP: rs76371115
rs76371115
0.010 GeneticVariation BEFREE These individuals and 50 patients with pHPT without pancreatitis were analyzed for mutations in the serine protease inhibitor Kazal type I (SPINK1) gene (N34S) and the cationic trypsinogen gene (PRSS1) (N29I, R122H) by melting curve analysis and DNA sequencing. 18076731

2008

dbSNP: rs775437927
rs775437927
0.010 GeneticVariation BEFREE These individuals and 50 patients with pHPT without pancreatitis were analyzed for mutations in the serine protease inhibitor Kazal type I (SPINK1) gene (N34S) and the cationic trypsinogen gene (PRSS1) (N29I, R122H) by melting curve analysis and DNA sequencing. 18076731

2008

dbSNP: rs777418530
rs777418530
0.010 GeneticVariation BEFREE Four of 25 patients with pHPT and pancreatitis carried the N34S missense mutation in the SPINK1 gene (16%), while all 50 controls (pHPT without pancreatitis) showed no mutation in SPINK1 or PRSS1 genes (P < 0.05 vs controls, P < 0.001 vs general population). 18076731

2008

dbSNP: rs121913228
rs121913228
0.010 GeneticVariation BEFREE A protein-stabilizing mutation in exon 3 of beta-catenin (S37A) was detected in three of 20 pHPT tumors (15%). 17047023

2007

dbSNP: rs1485866385
rs1485866385
APC
0.010 GeneticVariation BEFREE A protein-stabilizing mutation in exon 3 of beta-catenin (S37A) was detected in three of 20 pHPT tumors (15%). 17047023

2007

dbSNP: rs74799832
rs74799832
RET
0.010 GeneticVariation BEFREE One patient having a mutation in exon 16 (Met918Thr) presented with the MEN2B phenotype, six patients from two families had hereditary MTC without pheochromocytoma (pheo) and primary hyperparathyroidism (PHPT), whereas 33 patients from 15 families showed the MEN2A phenotype. 16865647

2006